Article
Comparative Study of Effects of Vonoprazan and Esomeprazole on Antiplatelet Function of Clopidogrel or Prasugrel in Relation to CYP2C19 Genotype.
Clinical pharmacology and therapeutics - 1 May 2018
Kagami Takuma, Yamade Mihoko, Suzuki Takahiro, Uotani Takahiro, Hamaya Yasushi, Iwaizumi Moriya, Osawa Satoshi, Sugimoto Ken, Umemura Kazuo, Miyajima Hiroaki, Furuta Takahisa
Abstract excerpt
Drug-drug interaction between antiacid and antiplatelet agents has not been fully elucidated. Vonoprazan, a new potassium competitive acid blocker, has been available in Japan. CYP2C19 and CYP3A4 are involved in the metabolism of clopidogrel, prasugrel, esomeprazole, and vonoprazan. Using a P2Y12 assay, we compared the effects of vonoprazan and esomeprazole on the antiplatelet functions of clopidogrel or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
